Aprea Therapeutics Inc.

APRE | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.74

-$0.02 (-2.62%)

At close: Sep 21, 2026, 4:00 PM ET

$0.77

+$0.03 (+4.05%)

Pre-market: Sep 22, 2026, 4:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-12.6M	-12.96M	-14.29M	-112.66M	-37.13M	-53.48M
Depreciation & Amortization	21.72K	22.32K	7.05K	186.45K	271.68K	229.61K
Stock-Based Compensation	478.14K	489.44K	444.46K	16.98M	7.81M	4.98M
Other Working Capital	-282.39K	-741.19K	791.25K	-900.07K	-5.6M	3.25M
Other Non-Cash Items	134.37K	-54.37K	38.93K	72.24M	-317.4K	890.25K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-929.1K	-1.06M	1.62M	-1.76M	-8.33M	5.57M
Operating Cash Flow	-12.89M	-13.56M	-12.18M	-25.01M	-37.69M	-41.8M
Capital Expenditures	n/a	-15.48K	-93.09K	n/a	n/a	-25.71K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	-15.48K	-93.09K	n/a	n/a	-25.71K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-407.46K	-1.32M	-648.93K	n/a	208.37K	n/a
Financial Cash Flow	4.64M	14.82M	5.14M	682.97K	1.75M	150.95K
Net Cash Flow	-8.25M	1.24M	-7.14M	-24.29M	-35.94M	-41.07M
Free Cash Flow	-12.89M	-13.57M	-12.27M	-25.01M	-37.69M	-41.83M
Adj. Free Cash Flow	-13.37M	-14.06M	-12.72M	-41.99M	-45.5M	-46.81M
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	-25.71K
Growth CapEx	n/a	-15.48K	-93.09K	n/a	n/a	n/a
Owner Earnings	-12.89M	-13.56M	-12.18M	-25.01M	-37.69M	-41.83M